Ovarian cancer is a very real threat to women, not only due to the serious nature of cancer but due to the fact that it is one of the hardest forms of cancer to detect. Figures show that early detection of the disease will encourage a 90% survival rate of sufferers whilst the rate drops considerably to just 30% if it is detected at a later stage. Researchers are using every possible method to find new processes, which will increase the chances of the cancer being detected at the earliest possible stage. Medical equipment from expert sources including http://www.broschdirect.com, screening abilities such as scanning opportunities, and typical patient care, are all being reviewed and tests are being held to pinpoint the exact method that will potentially save thousands of lives.


Ovarian cancer cells are notoriously hard to see in the earliest stages and are potentially fatal once they have been determine in the latter stages of the disease. The window of fighting the cancer is very small when it comes to this form and there is a lot of pressure on medical professionals to spot the signs and the presence of the disease as quickly as possible. The symptoms, which accompany ovarian cancer, are limited, if they are present then they are often blamed on other conditions and ailments and screening for cancer is a last resort. Tumours are easily missed and current identification methods are often left too late which results in a larger battle to fight the cancer, if treatment is still possible.

screening2The latest developments in the screening processes means that the cancer cells can be detected at the earliest opportunity. There is a certain protein which is present in the blood that can indicate the cancerous cells, those that have the protein will be tested regularly depending on how high the levels of protein are which will enable specialists to spot the ovarian cancer and begin the necessary treatment before it becomes too advanced. The discovery of protein is not a strong enough factor to diagnose cancer and treatment cannot begin until it is certain that ovarian cancer is the exact medical complaint. The regularly testing will ensure that any diagnosis is accurate.

Patients that have a higher risk of contracting cancer that are showing signs of protein in their blood will undergo a more intense screening routine to catch the cancer at the earliest stage.


During the recent medical studies, 10 women were found to have the early stages of ovarian cancer through the new screening process and they received treatment early enough to prevent their conditions from worsening and to eventually rid the body of cancer entirely. At the moment, the tests are only a small study and the results are not high enough to warrant an entire new system to be put in place until further testing has taken place. The results, however, do look promising and scientists are learning more about the disease and the early indications, which will eventually reduce the number of deaths to ovarian cancer.